The diagnostic specificity of CA125 for uterine leiomyosarcomas remains suboptimal, as elevations in serum levels may also manifest in a multitude of benign gynecological conditions and various other malignancies [3,58,59,60]. This evidence concerns the gene MUC16 and leiomyosarcoma.